“An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S33. doi:10.25251/skin.2.supp.32.